ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.
ICMR has partnered with @SerumInstIndia to conduct phase 2/3 bridging clinical trial of #COVOVAX. First three volunteers have been recruited today under the ICMR-SII NOVAVAX bridging study led by @IcmrNari at Nobel Hospital, Pune. @MoHFW_INDIA @DeptHealthRes @PIB_India pic.twitter.com/qxVf3dXJxz
— ICMR (@ICMRDELHI) March 25, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)